The primary purpose of the newly established Transgenic Mouse Shared Resource is to provide an efficient and economical means for producing genetically engineered mice for members of the Massey Cancer Center. Over the past 10 to 15 years, transgenic and """"""""knock-out"""""""" mice have become an indispensable tool in cancer research. The utility of such models ranges from studies of the basic biology of tumorigenesis and progression to the creation of genetically accurate tumor models for evaluating novel therapeutic approaches. The Transgenic Mouse Shared Resource will greatly facilitate the development and utilization of new mouse models for cancer by Massey Cancer Center investigators. Specific services provided by this Shared Resource include: 1) Transgenic mouse production. The core will generate at least three transgenic founder mice for each transgene. 2) Knock-out mouse production. The core can perform all or a subset of the following procedures: ES cell electroporation; ES cell culture under appropriate selection conditions; expansion of drug-resistant clones; Southern/PCR screening of clones for he correct recombination event; and injection of targeted ES cells into blastocysts for chimeric mouse production. 3) Mouse line rederivation. Lines of pathogen-infected mice will be rederived by embryo transfer to generate pathogen-free lines. 4) cre line X indicator line interbreeding. Liens of cre-expressing transgenic mice will be interbred to a core-maintained indicator line of mice (129-Gtrosa26/tm1/Sor) to permit characterization of cre expression. 5) Consulting/support services. The core provides consultation on general transgenic/knock-out approaches and on vector design and offers protocols and demonstrations of basic mouse husbandry techniques, including breeding strategies, weaning, ear punching and tail DNA isolation. 6) Embryo cryopreservation. In the second year of this funding period, the core will add embryo cryopreservation as a service, as a means of preserving lines of mice without active breeding and to safeguard against the loss of breeding lines due to disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016059-23
Application #
6596433
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-05-16
Project End
2007-04-30
Budget Start
Budget End
Support Year
23
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Nulton, Tara J; Kim, Nak-Kyeong; DiNardo, Laurence J et al. (2018) Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52-55
Porter-Stransky, Kirsten A; Centanni, Samuel W; Karne, Saumya L et al. (2018) Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal. Biol Psychiatry :
Cobb, Caroline O; Soule, Eric K; Rudy, Alyssa K et al. (2018) Patterns and Correlates of Tobacco and Cannabis co-use by Tobacco Product Type: Findings from the Virginia Youth Survey. Subst Use Misuse 53:2310-2319
Sonnenschein, Halie A; Lawrence, Kenneth F; Wittenberg, Karli A et al. (2018) Suppressor of IKKepsilon forms direct interactions with cytoskeletal proteins, tubulin and ?-actinin, linking innate immunity to the cytoskeleton. FEBS Open Bio 8:1064-1082
Curry, Zachary A; Wilkerson, Jenny L; Bagdas, Deniz et al. (2018) Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 366:169-183
Radwa?ska, Malwina J; Jaskó?owski, Mateusz; Davydova, Elena et al. (2018) The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab. Acta Crystallogr D Struct Biol 74:681-689
Ginder, Gordon D; Williams Jr, David C (2018) Readers of DNA methylation, the MBD family as potential therapeutic targets. Pharmacol Ther 184:98-111
Lancina 3rd, Michael G; Wang, Juan; Williamson, Geoffrey S et al. (2018) DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment. Mol Pharm 15:2883-2889
Vascak, Michal; Jin, Xiaotao; Jacobs, Kimberle M et al. (2018) Mild Traumatic Brain Injury Induces Structural and Functional Disconnection of Local Neocortical Inhibitory Networks via Parvalbumin Interneuron Diffuse Axonal Injury. Cereb Cortex 28:1625-1644
Chernoukhov, A; Hussein, A; Nkurunziza, S et al. (2018) Bayesian inference in time-varying additive hazards models with applications to disease mapping. Environmetrics 29:

Showing the most recent 10 out of 586 publications